Hope Pharmaceuticals (Scottsdale, Ariz) recently announced the release of Sodium Nitrite Injection USP 3% in singledose vials. This product is indicated for the treatment of cyanide poisoning. It is a primary component of the Cyanide Antidote Kit, which is used by hospitals and public safety authorities for emergency preparedness. Cyanide inhalation can cause severe toxic effects and death within minutes to hours. Prompt treatment is critical for patient survival. The new vials facilitate rapid administration during an emergency. For more information, visit www.hopepharm.com.